A different perspective on Vietnam’s economy and doing business in Vietnam. Make sure to subscribe.
Tag: pharmaceuticals
The Pharmaceuticals category covers drug manufacturing, distribution, regulatory policies, and healthcare market trends. It explores intellectual property laws, research and development, trade policies, and investment opportunities, providing insights into global supply chains, pricing, and healthcare access.
Pharmaceutical products: Vietnam imports surge by 10.29 percent in May
Vietnam’s imports of pharmaceutical products reached US$369.17 million in May 2025, according to figures released by Vietnam’s General Department of Customs. This represents a significant increase of 10.29 percent compared to April, bringing the year-to-date (YTD) import value to US$1.66 billion.
Pharmaceutical materials: Vietnam imports down 15.34 percent in April
Vietnam’s imports of pharmaceutical materials reached US$44.55 million in April 2025, according to figures released by Vietnam’s General Department of Customs. This represents a decrease of 15.34 percent compared to March, with a year-to-date (YTD) import value of US$172.91 million.
Pharmaceutical products: Vietnam imports down 3.08 percent in April, imports from US jump
Vietnam’s imports of pharmaceutical products reached US$334.74 million in April 2025, according to figures released by Vietnam’s General Department of Customs. This represents a slight decrease of 3.08 percent compared to March, with a year-to-date (YTD) import value of US$1.29 billion.
Vietnam’s pharmaceutical product imports slipped 4.25 percent in March
Vietnam imported US$345.38 million worth of pharmaceutical products in March, down 4.25 percent from February, according to Vietnam’s General Department of Customs. Total year-to-date imports reached US$958.42 million.
Vietnam’s pharmaceutical material imports surged over 34 percent in March
Vietnam imported US$52.62 million worth of pharmaceutical materials in March, up 34.24 percent from February, according to Vietnam’s General Department of Customs. This brought the total value for the first quarter to US$128.40 million.
Vietnam’s Pharmaceuticals Law 2025: Key Provisions & Enforcement
Vietnam’s Pharmaceuticals Law regulates the production, distribution, and use of pharmaceutical products to ensure their safety, efficacy, and quality. It establishes strict standards for drug registration, licensing, and compliance, and mandates oversight by the Ministry of Health to protect public health and promote the development of the domestic pharmaceutical industry.
Vietnam drug and medical service costs increase in February: CPI data
Drug and medical service costs in Vietnam rose by 0.31 percent in February, driven by higher medical service fees and increased demand for medications, according to the Vietnam’s Consumer Price Index. The medical services price index increased by 0.36 percent following the implementation of new service pricing under Circular No. 21/2024/TT-BYT, issued by the Ministry of Health.
Vietnam’s imports of pharmaceutical materials surge by 35.5 percent in December
China remained the leading supplier, contributing US$38.90 million, a 19.54 percent increase from the previous month. India experienced significant growth, with imports surging by 157.30 percent to US$9.18 million. South Korea saw the most dramatic rise, with imports increasing by 1,520.56 percent to US$386,163, while Spain recorded a 395.88 percent increase to US$326,801.
Vietnam Pharmaceuticals Industry 2025: Growth, Imports & Key Players
Vietnam’s pharmaceuticals industry is experiencing robust growth, driven by increasing health awareness, rising demand for medications, and supportive government policies. With a focus on both traditional and modern healthcare solutions, the market is seeing a shift towards locally produced pharmaceuticals, which are often favoured for their affordability and relevance to local health needs.
Vietnam’s pharmaceutical product imports surge by 68.56 percent in December
The USA led the surge, with imports skyrocketing by 331.62 percent to US$101.02 million. India and South Korea also showed significant growth, with imports increasing by 85.26 percent and 139.22 percent, respectively. Belgium recorded an impressive 92.25 percent growth, contributing US$28.03 million in December.
Vietnam’s pharmaceutical production grows steadily in 2024
Year-on-year, the sector posted a modest growth of 0.5 percent in December compared to December 2023. However, for the full year of 2024, cumulative growth reached 7.3 percent compared to 2023, highlighting consistent annual progress.
Vietnam medicines and medical services prices up in December 2024
For the full year, the sector experienced a significant rise of 7.16 percent compared to 2023, reflecting ongoing cost pressures and increased demand for healthcare services and pharmaceuticals.
Vietnam’s pharmaceutical production shows steady monthly growth in November
Year-on-year, the sector recorded a slight decline of 0.81 percent in November 2024 compared to the same period in 2023. However, for the first 11 months of 2024, the pharmaceutical sector achieved cumulative growth of 8.15 percent compared to the same period last year, underlining its steady expansion over the year.
Vietnam medicines, medical services prices report sharp November decline
The Consumer Price Index (CPI) for medicines and medical services in Vietnam experienced a significant decrease of 3 percent in November compared to October, reaching 5.28 percent, according to Vietnam’s General Statistics Office.
Vietnam Report releases list of top pharma companies, pharma distributors
Market research firm Vietnam Report has compiled a list of the top ten pharmaceutical companies in Vietnam and the top ten pharmaceutical distributors. The results were determined by looking at the firms’ financial performance and analysing media coverage as well as through a survey conducted between October and November of this year…
Vietnam’s pharmaceutical sector shows steady growth with strong year-to-date increase
Year-over-year, the sector grew by 5.9 percent compared to October 2023, while the cumulative increase from January to October was 9.8 percent over the same period last year. These figures highlight the sector’s sustained expansion, which aligns with Vietnam’s focus on its healthcare infrastructure and localising pharmaceutical production to reduce reliance on imports…
Vietnam’s CPI for medicines and medical services shows substantial year-to-date increase
For the period from January to October 2024, the CPI for medicines and medical services rose by 7.54 percent over the same period in 2023. This sustained year-to-date growth reflects growing demand for healthcare services, potential supply chain challenges, and rising input costs for pharmaceuticals.
Delayed payments, bidding challenges behind drug shortages in Vietnam
One of the issues raised was the challenges for public hospitals in being reimbursed for pharmaceutical purchases by the state hindering their ability to make timely payments to pharmaceutical companies. The Minister told the NA that this has been addressed with amendments made to the Law on Health insurance made last year, however, the Minister, based on Thanh Nien’s reporting, does not appear to have detailed which parts of the law or how they have worked in a practical sense…
Vietnam’s pharmaceutical production increase 1 point on Industrial Production Index
Compared to the same period last year, the pharmaceutical sector posted an impressive 15.4 percent increase, highlighting robust year-on-year growth driven by rising demand for medical products. For the first nine months of 2024, production in this category grew by 10.6 percent over the same period in 2023. This sustained growth reflects Vietnam’s efforts to expand its domestic pharmaceutical production capabilities.
Vietnam pharmaceutical materials imports fall 20.41 percent in September over August
Despite a 16.91 percent decline in imports from China (dropping from US$28,664,787 to US$23,817,031), China continues to be Vietnam’s top supplier of pharmaceutical materials, with a year-to-date total of US$245,220,442…
Q1 2025
We’re looking for a self-starting freelance Business Development Manager to help shape and grow the-shiv’s commercial strategy. You’ll be responsible for identifying new revenue opportunities, pitching services, and building partnerships.